symptom
viral
upper
respiratori
infect
uri
usual
overlap
allerg
rhiniti
ar
nasal
obstruct
rhinorrhea
sneez
patient
ar
mistakenli
believ
repeat
viral
infect
manifest
common
cold
furthermor
difficult
differenti
symptom
ar
aggrav
viral
uri
symptom
although
clearli
distinct
share
common
clinic
featur
pathogenet
relat
condit
fulli
understood
theoret
possibl
allergeninduc
inflamm
mucos
swell
nasal
caviti
paranas
sinus
patient
ar
may
make
suscept
viral
bacteri
infect
despit
assumpt
interrel
condit
role
respiratori
virus
aggrav
factor
ar
establish
previou
studi
focus
sever
uri
symptom
patient
ar
cohort
studi
adult
patient
ar
show
higher
incid
respiratori
infect
especi
number
sever
episod
also
longer
total
durat
respiratori
infect
compar
adult
patient
without
allergi
contrast
prospect
studi
report
signific
differ
frequenc
durat
uri
adult
patient
ar
patient
without
allergi
viral
respiratori
infect
act
synergist
allergen
sensit
exposur
exacerb
allerg
asthma
domest
exposur
allergen
act
synergist
virus
sensit
patient
increas
risk
hospit
admiss
allerg
rhiniti
asthma
similar
clinic
epidemiolog
pathogenet
featur
furthermor
viral
respiratori
infect
frequent
upper
airway
lower
airway
presenc
respiratori
virus
upper
respiratori
tract
may
result
sever
nasal
mucos
inflamm
nasal
symptom
patient
ar
howev
date
exact
pathogenet
role
respiratori
virus
present
upper
airway
patient
ar
elucid
therefor
studi
basic
step
better
understand
role
respiratori
virus
pathogenesi
ar
detect
rate
respiratori
virus
patient
perenni
ar
par
without
uri
symptom
compar
control
patient
symptom
sever
ar
evalu
accord
presenc
respiratori
virus
onehundr
nineteen
adult
patient
enrol
septemb
june
depart
otolaryngolog
asan
medic
center
seoul
korea
recruit
base
histori
nasalocular
symptom
endoscop
examin
skin
prick
test
allergenspecif
ige
test
none
patient
chronic
ill
hypertens
diabet
mellitu
evid
viral
uri
within
week
screen
histori
chronic
rhinosinus
andor
nasal
polyp
uri
symptom
distinguish
ar
symptom
case
associ
symptom
includ
cough
malais
throat
discomfort
fever
chill
headach
addit
nasal
discharg
nasal
congest
sneez
studi
approv
institut
review
board
asan
medic
center
particip
provid
written
inform
consent
enrol
patient
par
defin
persist
allerg
symptom
least
year
posit
respons
dermatophagoid
farina
andor
dermatophagoid
pteronyssinu
preval
allergen
korea
use
skin
prick
test
allergenspecif
ige
test
posit
skin
prick
test
result
defin
wheal
diamet
least
mm
larger
neg
control
patient
includ
studi
must
experienc
symptom
sever
enough
requir
continu
treatment
studi
word
experienc
moder
sever
ar
symptom
accord
allerg
rhiniti
impact
asthma
guidelin
allerg
symptom
control
use
oral
antihistamin
patient
use
intranas
topic
steroid
exclud
patient
present
respiratori
disord
ar
includ
asthma
chronic
obstruct
pulmonari
diseas
also
exclud
studi
control
patient
healthi
volunt
volunt
requir
plan
surgeri
thyroid
mass
control
patient
histori
allergi
neg
respons
allergi
test
allerg
rhiniti
symptom
record
base
patient
express
symptom
symptom
record
collect
nasal
sampl
enrol
wateri
rhinorrhea
sneez
itch
nasal
obstruct
grade
accord
sever
within
rang
none
mild
moder
sever
score
sum
produc
total
nasal
symptom
score
tnss
nasal
lavag
sampl
collect
patient
outpati
clinic
sampl
size
approxim
equal
distribut
studi
period
lavag
fluid
obtain
wash
nasal
mucosa
ml
salin
use
syring
plastic
contain
patient
ask
forcibl
expel
nasal
content
plastic
contain
salin
wash
specimen
transport
immedi
laboratori
multiplex
polymeras
chain
reaction
pcr
respiratori
viru
detect
facilit
multiplex
pcr
rna
sampl
extract
ml
respiratori
specimen
use
qiaamp
viral
rna
kit
qiagen
gmbh
hilden
germani
revers
transcript
synthes
cdna
use
revertaid
first
strand
cdna
synthesi
kit
fermenta
burlington
ontario
canada
cdna
sampl
subject
multiplex
pcr
use
seeplex
ace
detect
kit
seeplex
seegen
inc
seoul
korea
accord
manufactur
instruct
briefli
ml
synthes
firststrand
cdna
primer
mix
multiplex
master
mix
taq
dna
polymeras
dntp
includ
ml
solut
ad
primer
mix
contain
intern
control
templat
primer
pair
valid
pcr
three
reaction
primer
mix
b
c
set
sampl
accord
kit
instruct
specif
primer
target
respiratori
viru
list
tabl
pcr
carri
use
follow
reaction
condit
initi
denatur
c
minut
cycl
c
second
c
minut
second
c
minut
second
final
extens
phase
c
minut
multiplex
pcr
product
visual
electrophoresi
agaros
gel
detect
rate
respiratori
virus
group
analyz
c
test
betweengroup
differ
age
analyz
use
student
test
par
group
differ
tnss
accord
detect
respiratori
viru
analyz
use
pair
test
numer
data
express
mean
ae
standard
deviat
spss
spss
inc
chicago
illinoi
use
statist
analysi
p
valu
less
consid
statist
signific
nasal
lavag
sampl
patient
par
control
patient
evalu
use
multiplex
pcr
sex
distribut
mean
age
patient
par
control
patient
similar
par
group
consist
men
women
mean
age
year
rang
control
group
without
allergi
consist
men
women
mean
age
year
rang
respiratori
virus
detect
nasal
lavag
sampl
patient
par
nasal
lavag
sampl
control
patient
detect
rate
respiratori
virus
higher
par
group
control
group
p
tabl
par
group
posit
sampl
posit
respiratori
viru
wherea
multipl
virus
detect
frequent
par
group
control
group
p
human
rhinoviru
hrv
commonli
detect
viru
nasal
lavag
fluid
par
control
group
detect
rate
hrv
greater
patient
par
control
patient
p
contrast
detect
rate
parainfluenza
virus
piv
second
common
type
respiratori
viru
significantli
differ
patient
par
control
patient
p
moreov
detect
rate
respiratori
virus
nasal
lavag
sampl
statist
signific
group
tabl
tnss
respiratori
viruseposit
par
group
ae
respiratori
viruseneg
par
group
ae
signific
differ
allerg
symptom
score
par
group
accord
detect
respiratori
virus
p
tnss
patient
hrvposit
par
higher
patient
hrvneg
par
wherea
tnss
patient
pivposit
par
lower
patient
pivneg
par
howev
statist
signific
base
detect
hrv
piv
p
respect
tabl
present
studi
respiratori
virus
detect
multiplex
pcr
patient
par
higher
patient
without
allergi
particular
detect
rate
overal
multipl
virus
hrv
significantli
higher
patient
par
patient
without
allergi
howev
differ
sever
ar
symptom
base
presenc
respiratori
viru
posit
detect
respiratori
viru
nasal
lavag
fluid
may
impli
subclin
persist
respiratori
viru
previou
infect
hrv
infect
persist
lower
respiratori
tract
longer
year
piv
also
detect
month
nasal
epitheli
cell
patient
postvir
olfactori
dysfunct
present
studi
detect
rate
patient
ar
control
patient
high
despit
evid
recent
uri
report
seeplex
detect
kit
high
sensit
specif
compar
convent
viral
cultur
coinfect
better
detect
multiplex
pcr
kit
viral
cultur
immunofluoresc
overal
detect
rate
respiratori
viru
higher
patient
par
control
specif
larger
proport
patient
respiratori
viruseposit
par
multipl
virus
nasal
lavag
fluid
compar
control
patient
without
allergi
although
clinic
signific
multipl
viru
detect
debat
impair
innat
immun
respons
patient
allergi
could
lead
multipl
viral
infect
research
report
patient
allerg
asthma
andor
ar
impair
innat
immun
respons
respiratori
viral
infect
impair
interferon
product
associ
allerg
sensit
may
increas
suscept
respiratori
viral
infect
compromis
viral
clearanc
lead
longterm
viral
shed
human
rhinoviru
trigger
acut
asthma
exacerb
increas
lower
airway
inflamm
bronchial
hyperrespons
moreov
persist
infect
hrv
may
associ
clinic
featur
sever
asthma
present
studi
hrv
detect
patient
par
similar
detect
rate
nasal
lavag
fluid
patient
chronic
rhinosinus
author
previou
multiplex
pcr
studi
furthermor
author
found
hrv
common
respiratori
viru
patient
par
control
patient
without
allergi
viru
show
signific
differ
par
control
group
result
suggest
hrv
could
play
major
role
pathogenesi
ar
exist
long
period
inflammatori
state
addit
hrv
detect
rate
piv
rel
high
nasal
lavag
sampl
par
control
group
show
signific
differ
group
find
may
due
tropism
piv
epitheli
cell
viral
respiratori
infect
induc
inflamm
nasal
sinu
caviti
patient
season
ar
inocul
nasal
outsid
pollen
season
exhibit
increas
respons
allergen
part
hrvinduc
stimul
eosinophil
neutrophil
activ
addit
combin
respiratori
viru
detect
allergen
exposur
increas
risk
acut
asthma
exacerb
therefor
author
sought
determin
whether
persist
respiratori
viru
could
aggrav
mucos
inflamm
patient
ar
subsequ
caus
sever
symptom
howev
studi
statist
signific
associ
ar
symptom
score
tnss
presenc
respiratori
virus
result
suggest
patient
respiratori
viruseposit
par
might
sever
allerg
symptom
compar
patient
respiratori
viruseneg
par
result
may
influenc
use
oral
antihistamin
par
group
discontinu
oral
antihistamin
toler
par
group
treatment
could
stop
studi
patient
studi
conduct
patient
par
without
evid
uri
patient
without
allergi
without
evid
uri
week
studi
assess
whether
presenc
respiratori
viru
could
affect
clinic
featur
par
author
studi
patient
par
season
ar
enrol
roughli
equal
sampl
size
month
nasal
allergi
symptom
patient
par
develop
throughout
year
author
tri
identifi
associ
sever
allerg
symptom
respiratori
viral
infect
limit
studi
nasal
lavag
sampl
use
detect
respiratori
virus
nasal
lavag
fluid
might
higher
falseposit
rate
owe
increas
risk
trap
virus
float
ambient
air
howev
distinct
observ
overal
multipl
viru
detect
rate
patient
par
higher
patient
without
allergi
therefor
studi
still
valuabl
show
relat
adult
patient
par
presenc
respiratori
virus
author
knowledg
previou
studi
investig
detect
respiratori
virus
patient
par
evid
viral
uri
present
result
rais
possibl
patient
par
vulner
respiratori
viral
infect
persist
respiratori
viral
infect
particular
hrv
conclus
present
find
show
high
preval
respiratori
virus
patient
par
suggest
respiratori
virus
might
play
role
pathogenesi
ar
confirm
clinic
signific
result
research
associ
symptom
aggrav
respiratori
viral
infect
larger
group
patient
ar
parallel
group
healthi
control
subject
need
